Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Aytu Bioscience Inc (AYTUD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 16,669
  • Shares Outstanding, K 4,220
  • Annual Sales, $ 3,220 K
  • Annual Income, $ -22,510 K
  • 36-Month Beta 5.21
  • Price/Sales 4.98
  • Price/Cash Flow N/A
  • Price/Book 0.85
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -48.16
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/06/17
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.3400 +22.75%
on 08/28/17
4.5000 -8.89%
on 09/14/17
-0.2000 (-4.65%)
since 08/25/17
3-Month
3.3400 +22.75%
on 08/28/17
12.0000 -65.83%
on 07/28/17
-7.6000 (-64.96%)
since 06/27/17
52-Week
3.3400 +22.75%
on 08/28/17
77.8000 -94.73%
on 10/04/16
-62.9000 (-93.88%)
since 09/27/16

Most Recent Stories

More News
Aytu BioScience Enters $1.8 Billion U.S. Prescription Sleep Aid Market with Exclusive License to Zolpimist(TM) to Expand Company's Commercial-Stage Product Portfolio

Company Acquires FDA-Approved, Commercial-Stage Product to Complement Natesto® Sales Efforts Among Primary Care Physicians

AYTUD : 4.1000 (+3.80%)
AYTU : 0.32 (+3.23%)
Aytu BioScience, Inc. to Present at the 8th Annual LD Micro Invitational Investor Conference

ENGLEWOOD, CO / ACCESSWIRE / May 23, 2018 / (NASDAQ: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, announced today that it will...

AYTUD : 4.1000 (+3.80%)
AYTU : 0.32 (+3.23%)
Aytu BioScience Provides Fiscal Third Quarter 2018 Business Update - Live Conference Call and Webcast Today at 4:30 pm ET

Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today provided an overview of its business, including...

AYTUD : 4.1000 (+3.80%)
LPBC : 12.5000 (unch)
AYTU : 0.32 (+3.23%)
Aytu BioScience CEO Issues Letter to Shareholders

ENGLEWOOD, CO / ACCESSWIRE / May 8, 2018 / (NASDAQ: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, has highlighted its progress...

AYTUD : 4.1000 (+3.80%)
AYTU : 0.32 (+3.23%)
Aytu BioScience to Report Fiscal Third Quarter 2018 Results and Business Update

Live Conference Call and Webcast Scheduled for May 14, 2018, at 4:30 p.m. ET

AYTUD : 4.1000 (+3.80%)
AYTU : 0.32 (+3.23%)
Aytu BioScience Featured in Local ABC News Segment (VIDEO): "UM Doctors Test New Medication for Treating Men with Low Testosterone; Nasal Testosterone Gel doesn't Appear to have Negative Side Effects, Doctors Say."

ENGLEWOOD, CO / ACCESSWIRE / May 3, 2018 / Aytu BioScience, Inc. (NASDAQ: AYTU) (the "Company"), a specialty life sciences company focused on global commercialization of novel products in the field of...

AYTUD : 4.1000 (+3.80%)
AYTU : 0.32 (+3.23%)
Aytu BioScience to Present at The MicroCap Conference on April 10th in New York City at the Essex House

ENGLEWOOD, CO / ACCESSWIRE / April 3, 2018 / Aytu BioScience, Inc. (NASDAQ: AYTU) (the "Company") will be presenting at this year's MicroCap Conference on Tuesday, April 10, 2018 at 10:30 am.

AYTUD : 4.1000 (+3.80%)
AYTU : 0.32 (+3.23%)
Aytu BioScience Announces Exercise of Underwriters' Over-Allotment Option

ENGLEWOOD, CO / ACCESSWIRE / March 28, 2018 / Aytu BioScience, Inc. (NASDAQ: AYTU) (the "Company"), a specialty life sciences company focused on global commercialization of novel products in the field...

AYTUD : 4.1000 (+3.80%)
AYTU : 0.32 (+3.23%)
Aytu BioScience Presents New Research Findings for Natesto(R) at the Endocrine Society's 100th Annual Meeting

Post-hoc Data Analysis Demonstrates Natesto's Restoration of Normal Testosterone Levels in Hypogonadal Men While Maintaining Normal Levels of Estradiol (E2) and Dihydrotestosterone (DHT), Which Are Frequently...

AYTUD : 4.1000 (+3.80%)
AYTU : 0.32 (+3.23%)
Tauriga Sciences Inc. Increases Equity Stake in Colorado Based NASDAQ Listed Biotechnology Firm Focused in the Medical Field of Urology

Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or the "Company"), engaged in building its business through the development, distribution, and licensing of proprietary products as well as the evaluation...

AYTUD : 4.1000 (+3.80%)
TAUG : 0.0005 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade AYTUD with:

Key Turning Points

2nd Resistance Point 4.2200
1st Resistance Point 4.1600
Last Price 4.1000
1st Support Level 4.0200
2nd Support Level 3.9400

See More

52-Week High 77.8000
Fibonacci 61.8% 49.3563
Fibonacci 50% 40.5700
Fibonacci 38.2% 31.7837
Last Price 4.1000
52-Week Low 3.3400

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar